secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0000950170-24-082477
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alpha Teknova reports Q2 2024 rev $9.4-9.6M, reaffirms FY guidance $35-38M
--------------------------------------------------------------------------

- Q2 2024 total revenue $9.4-9.6M, down 17-18% YoY but up 7-9% adjusting for large prior-year order.
- FY 2024 revenue guidance reaffirmed at $35-38M; free cash outflow <$18M.
- Headcount reduced >40% from Q2 2022 peak to 169; cash used in Q2 was $3.0-3.4M.
- Clinical Solutions customers grew from 34 to 43; Lab Essentials customers from 2,829 to 2,913.
- No single direct customer >$1M YTD; full Q2 results expected August 13, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017024082477/0000950170-24-082477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017024082477/tkno-20240709.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-082477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer